Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover Study

Journal of Alzheimer s Disease(2020)10.3233/jad-191265Source: DataRank Database

Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover Study is a research paper published in Journal of Alzheimer s Disease (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.92)OA: greenTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Masood Manoochehri ORCID,Nicole M. Armstrong ORCID,Venkata S. Mattay ORCID,José Apud,Mary C. Tierney ORCID

Live enrichment

PubMed:32444540 PMC:PMC10131251 OpenAlex:https://openalex.org/W3028120429

NINDS NIH HHS

Grant: R00 NS060766

NIMH NIH HHS

Grant: R25 MH086466

FWCI

0.92

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2025

greenLicense: https://journals.sagepub.com/page/policies/text-and-data-mining-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10131251/pdf/nihms-1890177.pdf

publisherhttps://journals.sagepub.com/doi/pdf/10.3233/JAD-191265

publisherhttps://journals.sagepub.com/doi/full-xml/10.3233/JAD-191265

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10131251

Fields of Study

Amyotrophic Lateral Sclerosis ResearchEpilepsy research and treatmentDementia and Cognitive Impairment Research

MeSH Terms

TolcaponeAgedAged, 80 and overBehavioral SymptomsBrainCognitionDouble-Blind MethodFemaleHumansMaleMiddle AgedTreatment OutcomeCross-Over StudiesFrontotemporal DementiaCatechol O-Methyltransferase Inhibitors

Keywords

PlaceboPsychologyCrossover studyRepeatable Battery for the Assessment of Neuropsychological StatusFrontotemporal dementiaDementiaInternal medicineNeuropsychologyMedicinePsychiatryCognitionDiseaseDopamineTreatmentCOMTTolcapone

Sustainable Development Goals

SDG 0: Good health and well-being